Top news of the week: 06.05.2021.
Healthcare
Six patients with dementia went to Mexico for an unproven gene therapy, a biotech CEO claims
The study is part of an effort by entrepreneurs and scientists, dreamers and schemers, to demonstrate aging is not inevitable.
ALS groups to the FDA and drug sponsors: ‘We won’t be played again’
The FDA and pharma companies politely nod when listening to ALS patients, caregivers, and advocates, but don't take action.
Money on the Move: April 29 – May 4
April showers bring May dollars. Here's whose cash gardens are really blooming this week in the life sciences world.
Biotech Startup Series: The Path to IND
The Path to IND The Biotech Start-up Series of conferences and webinars focuses on healthcare entrepreneurship, gathering American & European entrepreneurs, researchers and experts to ...
Four New Biotechs to Watch: Esker, Mogrify, Isolere and BridGene
There’s money on the move and venture capital firms launch several biotech companies with hefty Series A financing rounds. Here’s a look.
Cumulus Neuroscience Announces £6 million Funding Round Led by the Dementia Discovery Fund and joined by LifeArc and UK Future Fund
/PRNewswire/ -- Cumulus Neuroscience (Cumulus, The Company), formerly known as BrainWaveBank, announces a £6m financing round led by the Dementia Discovery...
COVID Innovations: Vaccines for Variants, Drone Deliveries, Print-Your-Own Shots, and More
Next-generation COVID-19 vaccines will not only tackle different versions of the virus but will provide solutions across the world at a fraction of the cost
Episode 35: Galapagos UK’s Michael Smyth on RNA-based technology and market access
The new episode of the pharmaphorum podcast also hears about some of pharma’s UK launch challenges and the types of evidence that HTA bodies need for RNA-based drugs